These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7535946)

  • 41. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
    Heeb MJ; España F
    Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Purification and properties of rat stomach kallikrein.
    Uchida K; Niinobe M; Kato H; Fujii S
    Biochim Biophys Acta; 1980 Aug; 614(2):501-10. PubMed ID: 6157423
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in plasma levels of prekallikrein, kallikrein, high molecular weight kininogen and kallikrein inhibitors during lethal endotoxin shock in dogs.
    Gallimore MJ; Aasen AO; Amundsen E
    Haemostasis; 1978; 7(2-3):79-84. PubMed ID: 658781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characterization of human salivary kallikrein: reactivities to human plasma kininogens and proteinase inhibitors.
    Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O
    J Biochem; 1983 Mar; 93(3):833-8. PubMed ID: 6553577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absorption studies with porcine pancreatic kallikrein in man.
    Miska W; Geiger R; Schill WB
    Agents Actions Suppl; 1992; 38 ( Pt 2)():136-43. PubMed ID: 1462822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of high molecular weight kininogen in modulating the inactivation of human plasma kallikrein by plasma protease inhibitors.
    Schapira M; James A; Scott CF; Kueppers F; James HL; Cohen AB; Colman RW
    Adv Exp Med Biol; 1983; 156():131-41. PubMed ID: 6190364
    [No Abstract]   [Full Text] [Related]  

  • 47. [Benzoyl-kallikrein: kallikrein activity and kinin generation in plasma].
    Müller H; Stürzebecher J; Markwardt F
    Biomed Biochim Acta; 1986; 45(7):941-4. PubMed ID: 3641630
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interaction of plasma kallikrein with plasma proteinase inhibitors.
    Salvesen G; Virca GD; Travis J
    Adv Exp Med Biol; 1983; 156():121-30. PubMed ID: 6190363
    [No Abstract]   [Full Text] [Related]  

  • 49. In vivo catabolism of human kallikrein-binding protein and its complex with tissue kallikrein.
    Xiong W; Tang CQ; Zhou GX; Chao L; Chao J
    J Lab Clin Med; 1992 May; 119(5):514-21. PubMed ID: 1583408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of binding of pancreatic and urinary kallikreins to alpha 2-macroglobulin.
    Vahtera E; Hamberg U
    Biochem J; 1976 Aug; 157(2):521-4. PubMed ID: 61028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated kallikrein activity in plasma from stable liver transplant recipients.
    Hayashi J; Salomon DR; Hugli TE
    Int Immunopharmacol; 2002 Nov; 2(12):1667-80. PubMed ID: 12469941
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kinin activation and protease inhibitors in acute pancreatitis in man.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1986; 198 Pt B():423-32. PubMed ID: 2433917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Substrate specificities of tissue kallikrein and T-kininogenase: their possible role in kininogen processing.
    Chagas JR; Hirata IY; Juliano MA; Xiong W; Wang C; Chao J; Juliano L; Prado ES
    Biochemistry; 1992 Jun; 31(21):4969-74. PubMed ID: 1599922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Plasma half-life and organ uptake ratio of radiolabeled glandular kallikrein in control and nephrectomized rats.
    Nishimura K; Iwata T; Kokubu T
    Adv Exp Med Biol; 1986; 198 Pt A():309-13. PubMed ID: 3643714
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of urinary alpha1-antitrypsin in Padutin (kallikrein) inactivation.
    Hörl WH; Schäfer RM; Heidland A
    Eur J Clin Pharmacol; 1982; 22(6):541-4. PubMed ID: 6182004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Generation of an esterolytic and kinin-forming kallikrein-alpha2-macroglobulin complex in human serum by treatment with acetone.
    Vogt V; Dugal B
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):75-84. PubMed ID: 63921
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma prekallikrein assay: reversible inhibition of C-1 inhibitor by chloroform and its use in measuring prekallikrein in different mammalian species.
    Schmaier AH; Gustafson E; Idell S; Colman RW
    J Lab Clin Med; 1984 Dec; 104(6):882-92. PubMed ID: 6209352
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Purification and some physico-chemical and enzymatic properties of tissue kallikrein from human urine].
    Rabinovich SE; Lobareva LS; Paskhina TS
    Biokhimiia; 1990 Sep; 55(9):1675-89. PubMed ID: 2078641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of human bronchial kallikrein in asthma.
    Christiansen SC; Zuraw BL; Proud D; Cochrane CG
    Am Rev Respir Dis; 1989 May; 139(5):1125-31. PubMed ID: 2785358
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of kinin release during experimental acute pancreatitis in rats: evidence for pro- as well as anti-inflammatory roles of oedema formation.
    Griesbacher T; Rainer I; Tiran B; Fink E; Lembeck F; Peskar BA
    Br J Pharmacol; 2003 May; 139(2):299-308. PubMed ID: 12770935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.